PMC:7029610 / 6441-6979 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"99","span":{"begin":0,"end":9},"obj":"Species"},{"id":"100","span":{"begin":388,"end":397},"obj":"Species"},{"id":"101","span":{"begin":398,"end":406},"obj":"Species"},{"id":"102","span":{"begin":481,"end":490},"obj":"Species"},{"id":"103","span":{"begin":491,"end":499},"obj":"Species"},{"id":"104","span":{"begin":250,"end":269},"obj":"Chemical"},{"id":"105","span":{"begin":92,"end":114},"obj":"Disease"},{"id":"106","span":{"begin":416,"end":425},"obj":"Disease"},{"id":"107","span":{"begin":468,"end":477},"obj":"Disease"}],"attributes":[{"id":"A99","pred":"tao:has_database_id","subj":"99","obj":"Tax:2697049"},{"id":"A100","pred":"tao:has_database_id","subj":"100","obj":"Tax:2697049"},{"id":"A101","pred":"tao:has_database_id","subj":"101","obj":"Tax:9606"},{"id":"A102","pred":"tao:has_database_id","subj":"102","obj":"Tax:2697049"},{"id":"A103","pred":"tao:has_database_id","subj":"103","obj":"Tax:9606"},{"id":"A104","pred":"tao:has_database_id","subj":"104","obj":"MESH:C558899"},{"id":"A105","pred":"tao:has_database_id","subj":"105","obj":"MESH:D020879"},{"id":"A106","pred":"tao:has_database_id","subj":"106","obj":"MESH:D003643"},{"id":"A107","pred":"tao:has_database_id","subj":"107","obj":"MESH:D003643"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"2019-nCoV management was largely supportive, including intubation, early prone positioning, neuromuscular blockade, and extracorporeal membrane oxygenation (ECMO) according to the recommendations updated by CNHC. Low-dose systematic corticosteroids, lopinavir/ritonavir, and atomization inhalation of interferon were encouraged. These critical managements have worked well so far, as our 2019-nCoV patients had zero mortality. On the contrary, the previously reported mortality of 2019-nCoV patients in Wuhan ranged from 11 to 15% [1, 9]."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T37","span":{"begin":0,"end":9},"obj":"SP_7"},{"id":"T36","span":{"begin":144,"end":155},"obj":"GO:0015671"},{"id":"T35","span":{"begin":233,"end":248},"obj":"CHEBI:50858;CHEBI:50858"},{"id":"T34","span":{"begin":250,"end":259},"obj":"CHEBI:31781;CHEBI:31781;DG_23"},{"id":"T33","span":{"begin":260,"end":269},"obj":"DG_30"},{"id":"T32","span":{"begin":388,"end":397},"obj":"SP_7"},{"id":"T31","span":{"begin":481,"end":490},"obj":"SP_7"}],"text":"2019-nCoV management was largely supportive, including intubation, early prone positioning, neuromuscular blockade, and extracorporeal membrane oxygenation (ECMO) according to the recommendations updated by CNHC. Low-dose systematic corticosteroids, lopinavir/ritonavir, and atomization inhalation of interferon were encouraged. These critical managements have worked well so far, as our 2019-nCoV patients had zero mortality. On the contrary, the previously reported mortality of 2019-nCoV patients in Wuhan ranged from 11 to 15% [1, 9]."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T27","span":{"begin":135,"end":143},"obj":"http://purl.obolibrary.org/obo/UBERON_0000158"},{"id":"T28","span":{"begin":521,"end":523},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"}],"text":"2019-nCoV management was largely supportive, including intubation, early prone positioning, neuromuscular blockade, and extracorporeal membrane oxygenation (ECMO) according to the recommendations updated by CNHC. Low-dose systematic corticosteroids, lopinavir/ritonavir, and atomization inhalation of interferon were encouraged. These critical managements have worked well so far, as our 2019-nCoV patients had zero mortality. On the contrary, the previously reported mortality of 2019-nCoV patients in Wuhan ranged from 11 to 15% [1, 9]."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T2","span":{"begin":233,"end":248},"obj":"Chemical"},{"id":"T3","span":{"begin":250,"end":269},"obj":"Chemical"},{"id":"T4","span":{"begin":250,"end":259},"obj":"Chemical"},{"id":"T5","span":{"begin":260,"end":269},"obj":"Chemical"},{"id":"T6","span":{"begin":301,"end":311},"obj":"Chemical"}],"attributes":[{"id":"A2","pred":"chebi_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_50858"},{"id":"A3","pred":"chebi_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CHEBI_145924"},{"id":"A4","pred":"chebi_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/CHEBI_31781"},{"id":"A5","pred":"chebi_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/CHEBI_45409"},{"id":"A6","pred":"chebi_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/CHEBI_52999"}],"text":"2019-nCoV management was largely supportive, including intubation, early prone positioning, neuromuscular blockade, and extracorporeal membrane oxygenation (ECMO) according to the recommendations updated by CNHC. Low-dose systematic corticosteroids, lopinavir/ritonavir, and atomization inhalation of interferon were encouraged. These critical managements have worked well so far, as our 2019-nCoV patients had zero mortality. On the contrary, the previously reported mortality of 2019-nCoV patients in Wuhan ranged from 11 to 15% [1, 9]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T50","span":{"begin":0,"end":212},"obj":"Sentence"},{"id":"T51","span":{"begin":213,"end":328},"obj":"Sentence"},{"id":"T52","span":{"begin":329,"end":426},"obj":"Sentence"},{"id":"T53","span":{"begin":427,"end":538},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"2019-nCoV management was largely supportive, including intubation, early prone positioning, neuromuscular blockade, and extracorporeal membrane oxygenation (ECMO) according to the recommendations updated by CNHC. Low-dose systematic corticosteroids, lopinavir/ritonavir, and atomization inhalation of interferon were encouraged. These critical managements have worked well so far, as our 2019-nCoV patients had zero mortality. On the contrary, the previously reported mortality of 2019-nCoV patients in Wuhan ranged from 11 to 15% [1, 9]."}